Related Experiment Videos
High density lipoprotein, apolipoprotein A-I, and coronary artery disease
1Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA. ajits@esperion.com
Insights
High density lipoproteins (HDL) are key for reverse cholesterol transport and may protect against heart disease. Understanding HDL regulation, particularly apolipoprotein A-I (apoA-I) gene expression, is crucial for managing cardiovascular health.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Molecular Genetics
Background:
- High density lipoproteins (HDL) are central to reverse cholesterol transport.
- Elevated HDL levels are associated with protection against coronary heart disease.
- HDL's role in cholesterol removal and atherosclerosis regression highlights the need to understand its regulation.
Purpose of the Study:
- To review pathways that modulate plasma HDL levels.
- To explore the regulation of apolipoprotein A-I (apoA-I) gene expression.
- To provide insights into increasing plasma HDL levels for cardiovascular health.
Main Methods:
- Literature review of molecular and cellular processes affecting HDL.
- Analysis of factors influencing apoA-I gene expression.
- Synthesis of current understanding on HDL metabolism and regulation.
Main Results:
- HDL plays a vital role in cholesterol homeostasis and cardiovascular protection.
- Apolipoprotein A-I (apoA-I) is the primary determinant of plasma HDL levels.
- Understanding apoA-I gene regulation is key to manipulating HDL levels.
Conclusions:
- Modulating factors that affect HDL plasma levels can influence coronary artery disease risk.
- Targeting apoA-I gene expression offers a potential strategy for raising HDL levels.
- Further research into HDL regulation is essential for developing novel therapeutic approaches.
Abstract:
High density lipoproteins (HDL), one of the main lipoprotein particles circulating in plasma, is involved in the reverse cholesterol transport. Several lines of evidence suggest that elevated levels of HDL is protective against coronary heart disease. The role of HDL in the removal of body cholesterol and in the regression of atherosclerosis add to the importance of understanding the molecular-cellular processes that determine plasma levels of HDL. Factors modulating plasma levels of HDL may have influence on the predisposition of an individual to premature coronary artery disease. Apolipoprotein (apo) A-I is the main apolipoprotein component of HDL and, to a large extent, sets the plasma levels of HDL. Thus, understanding the regulation of apoA-I gene expression may provide clues to raise plasma levels of HDL. This review discusses the various pathways that alter plasma levels of HDL. Since apoA-I is the main protein component of HDL and determines the plasma levels of HDL, this review also covers the regulation of apoA-I gene expression.